You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR BUSPAR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BUSPAR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00174226 ↗ Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar Completed Pfizer Phase 2 2004-11-01 Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
NCT00178971 ↗ Serotonin 1A Agonists and Cognition in Schizophrenia Completed National Alliance for Research on Schizophrenia and Depression Phase 3 2003-01-01 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antipsychotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
NCT00178971 ↗ Serotonin 1A Agonists and Cognition in Schizophrenia Completed Northwestern University Phase 3 2003-01-01 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antipsychotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BUSPAR

Condition Name

Condition Name for BUSPAR
Intervention Trials
Spinal Cord Injuries 3
Healthy 2
To Determine Bioequivalence Under Fed Conditions 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BUSPAR
Intervention Trials
Spinal Cord Injuries 4
Disease 3
Wounds and Injuries 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BUSPAR

Trials by Country

Trials by Country for BUSPAR
Location Trials
United States 26
Canada 3
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BUSPAR
Location Trials
Massachusetts 4
Texas 3
Kentucky 2
Maryland 2
North Dakota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BUSPAR

Clinical Trial Phase

Clinical Trial Phase for BUSPAR
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BUSPAR
Clinical Trial Phase Trials
Completed 13
Recruiting 5
Withdrawn 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BUSPAR

Sponsor Name

Sponsor Name for BUSPAR
Sponsor Trials
Spaulding Rehabilitation Hospital 2
Phoenix International Life Sciences, Inc. 2
Par Pharmaceutical, Inc. 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BUSPAR
Sponsor Trials
Other 16
Industry 7
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.